[Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D012293:Rifampin
La rifampicine. Etude de son activité anti-tuberculeuse et de sa tolérance hépatique chez 200 malades.